The effect of intra-nasal co-treatment with insulin and growth factor-rich serum on behavioral defects, hippocampal oxidative-nitrosative stress, and histological changes induced by icv-STZ in a rat model
- 29 December 2023
- journal article
- research article
- Published by Springer Nature in Naunyn-Schmiedeberg's Archives of Pharmacology
- Vol. 397 (7) , 4833-4849
Abstract
Impaired insulin and growth factor functions are thought to drive many alterations in neurodegenerative diseases like dementia and seem to contribute to oxidative stress and inflammatory responses. Recent studies revealed that nasal growth factor therapy could induce neuronal and oligodendroglia protection in rodent brain damage induction models. Impairment of several growth factors signaling was reported in neurodegenerative diseases. So, in the present study, we examined the effects of intranasal co-treatment of insulin and a pool of growth factor-rich serum (GFRS) which separated from activated platelets on memory, and behavioral defects induced by intracerebroventricular streptozotocin (icv-STZ) rat model also investigated changes in the hippocampal oxidative-nitrosative state and histology. We found that icv-STZ injection (3 mg/kg bilaterally) impairs spatial learning and memory in Morris Water Maze, leads to anxiogenic-like behavior in the open field arena, and induces oxidative-nitrosative stress, neuroinflammation, and neuronal/oligodendroglia death in the hippocampus. GFRS (1µl/kg, each other day, 9 doses) and regular insulin (4 U/40 µl, daily, 18 doses) treatments improved learning, memory, and anxiogenic behaviors. The present study showed that co-treatment (GFRS + insulin with respective dose) has more robust protection against hippocampal oxidative-nitrosative stress, neuroinflammation, and neuronal/oligodendroglia survival in comparison with the single therapy. Memory and behavioral improvements in the co-treatment of insulin and GFRS could be attributed to their effects on neuronal/oligodendroglia survival and reduction of neuroinflammation in the hippocampus. Graphical AbstractKeywords
All Related Versions
Funding Information
- Shiraz University of Medical Sciences (SUMS-97-01-01018475)
This publication has 80 references indexed in Scilit:
- Inflammatory process in Alzheimer's DiseaseFrontiers in Integrative Neuroscience, 2013
- Fiji: an open-source platform for biological-image analysisNature Methods, 2012
- Intranasal administration of insulin-like growth factor-1 protects against lipopolysaccharide-induced injury in the developing rat brainNeuroscience, 2011
- Linking Alzheimer's disease to insulin resistance: the FoxO response to oxidative stressMolecular Psychiatry, 2010
- AMPA receptors are exocytosed in stimulated spines and adjacent dendrites in a Ras-ERK–dependent manner during long-term potentiationProceedings of the National Academy of Sciences, 2010
- The vascular contribution to Alzheimer's diseaseClinical Science, 2010
- A blunted cortisol awakening response and hippocampal atrophy in type 2 diabetes mellitusPsychoneuroendocrinology, 2009
- Awake Intranasal Insulin Delivery Modifies Protein Complexes and Alters Memory, Anxiety, and Olfactory BehaviorsJournal of Neuroscience, 2009
- Hippocampal atrophy rates in Alzheimer diseaseNeurology, 2009
- Transcription Factors in Long-Term Memory and Synaptic PlasticityPhysiological Reviews, 2009